{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T05:10:07Z","timestamp":1748063407629,"version":"3.41.0"},"reference-count":27,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1620\/tjem.2024.j109","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T22:12:50Z","timestamp":1729116770000},"page":"37-46","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Clinicopathological Characteristics and Clinical Outcomes of Patients Who Developed Non-Muscle-Invasive Bladder Cancer After Radiotherapy for Prostate Cancer: A Retrospective Multicenter Study"],"prefix":"10.1620","volume":"266","author":[{"given":"Takuma","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Urology, Tohoku University Graduate School of Medicine"},{"name":"Tohoku Urological Evidence-Based Medicine Study Group"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Sano","sequence":"additional","affiliation":[{"name":"Department of Urology, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisanobu","family":"Adachi","sequence":"additional","affiliation":[{"name":"Department of Urology, Miyagi Cancer Center"},{"name":"Tohoku Urological Evidence-Based Medicine Study Group"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Urology, Osaki Citizen Hospital"},{"name":"Tohoku Urological Evidence-Based Medicine Study Group"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Takemoto","sequence":"additional","affiliation":[{"name":"Department of Urology, Kesennuma City Hospital"},{"name":"Tohoku Urological Evidence-Based Medicine Study Group"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Myoen","sequence":"additional","affiliation":[{"name":"Department of Urology, Hachinohe City Hospital"},{"name":"Tohoku Urological Evidence-Based Medicine Study Group"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Mitsuzuka","sequence":"additional","affiliation":[{"name":"Department of Urology, Japan Community Health Care Organization Sendai Hospital"},{"name":"Tohoku Urological Evidence-Based Medicine Study Group"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kyan","sequence":"additional","affiliation":[{"name":"Department of Urology, Shirakawa Kosei General Hospital"},{"name":"Tohoku Urological Evidence-Based Medicine Study Group"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Urology, Sendai Red Cross Hospital"},{"name":"Tohoku Urological Evidence-Based Medicine Study Group"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Tokuyama","sequence":"additional","affiliation":[{"name":"Department of Urology, Iwaki City Medical Center"},{"name":"Tohoku Urological Evidence-Based Medicine Study Group"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Urology, National Hospital Organization Sendai Medical Center"},{"name":"Tohoku Urological Evidence-Based Medicine Study Group"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Urology, Tohoku University Graduate School of Medicine"},{"name":"Tohoku Urological Evidence-Based Medicine Study Group"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Urology, Tohoku University Graduate School of Medicine"},{"name":"Tohoku Urological Evidence-Based Medicine Study Group"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Urology, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Urology, Tohoku University Graduate School of Medicine"},{"name":"Tohoku Urological Evidence-Based Medicine Study Group"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Abern, M.R., Dude, A.M., Tsivian, M. &amp; Coogan, C.L.(2013)  The characteristics of bladder cancer after radiotherapy for prostate cancer.  <i>Urol. Oncol<\/i>., 31, 1628-1634.","DOI":"10.1016\/j.urolonc.2012.04.006"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Armstrong, G.T., Liu, Q., Yasui, Y., Neglia, J.P., Leisenring, W., Robison, L.L. &amp; Mertens, A.C.(2009)  Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study.  <i>J. Clin. Oncol<\/i>., 27, 2328-2338.","DOI":"10.1200\/JCO.2008.21.1425"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Boorjian, S., Cowan, J.E., Konety, B.R., DuChane, J., Tewari, A., Carroll, P.R.,  Kane, C.J. &amp; Cancer of the Prostate Strategic Urologic Research Endeavor Investigators(2007)  Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavor.  <i>J. Urol<\/i>., 177, 883-887; discussion 887-888.","DOI":"10.1016\/j.juro.2006.10.071"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bostrom, P.J., Soloway, M.S., Manoharan, M., Ayyathurai, R. &amp; Samavedi, S.(2008)  Bladder cancer after radiotherapy for prostate cancer: detailed analysis of pathological features and outcome after radical cystectomy.  <i>J. Urol<\/i>., 179, 91-95; discussion 95.","DOI":"10.1016\/j.juro.2007.08.157"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Braunstein, S. &amp; Nakamura, J.L.(2013)  Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk.  <i>Front. Oncol<\/i>., 3, 73.","DOI":"10.3389\/fonc.2013.00073"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Chao, C., Bhatia, S., Xu, L., Cannavale, K.L., Wong, F.L., Huang, P.S., Cooper, R. &amp; Armenian, S.H.(2019)  Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.  <i>JAMA Netw. Open<\/i>, 2, e195536.","DOI":"10.1001\/jamanetworkopen.2019.5536"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Demoor-Goldschmidt, C. &amp; de Vathaire, F.(2019)  Review of risk factors of secondary cancers among cancer survivors.  <i>Br. J. Radiol<\/i>., 92, 20180390.","DOI":"10.1259\/bjr.20180390"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Deng, Z., Jones, M.R., Wang, M.C. &amp; Visvanathan, K.(2022)  Mortality after second malignancy in breast cancer survivors compared to a first primary cancer: a nationwide longitudinal cohort study.  <i>NPJ Breast Cancer<\/i>, 8, 82.","DOI":"10.1038\/s41523-022-00447-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Doll, R.(1995)  Hazards of ionising radiation: 100 years of observations on man.  <i>Br. J. Cancer<\/i>, 72, 1339-1349.","DOI":"10.1038\/bjc.1995.513"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Dracham, C.B., Shankar, A. &amp; Madan, R.(2018)  Radiation induced secondary malignancies: a review article.  <i>Radiat. Oncol. J<\/i>., 36, 85-94.","DOI":"10.3857\/roj.2018.00290"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Hegemann, N.S., Schlesinger-Raab, A., Ganswindt, U., Horl, C., Combs, S.E., Holzel, D., Gschwend, J.E., Stief, C., Belka, C. &amp; Engel, J.(2017)  Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis.  <i>Radiat. Oncol<\/i>., 12, 2.","DOI":"10.1186\/s13014-016-0738-z"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Huang, J., Kestin, L.L., Ye, H., Wallace, M., Martinez, A.A. &amp; Vicini, F.A.(2011)  Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer.  <i>Radiother. Oncol<\/i>., 98, 81-86.","DOI":"10.1016\/j.radonc.2010.09.012"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Huang, R.X. &amp; Zhou, P.K.(2020)  DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer.  <i>Signal Transduct. Target. Ther<\/i>., 5, 60.","DOI":"10.1038\/s41392-020-0150-x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Izumi, K., Taguri, M., Miyamoto, H., Hara, Y., Kishida, T., Chiba, K., Murai, T., Hirai, K., Suzuki, K., Fujinami, K., Ueki, T., Udagawa, K., Kitami, K., Moriyama, M., Miyoshi, Y.,  et al.(2014)  Androgen deprivation therapy prevents bladder cancer recurrence.  <i>Oncotarget<\/i>, 5, 12665-12674.","DOI":"10.18632\/oncotarget.2851"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Kanda, Y.(2013)  Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics.  <i>Bone Marrow Transplant<\/i>., 48, 452-458.","DOI":"10.1038\/bmt.2012.244"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Kendal, W., Eapen, L. &amp; Nicholas, G.(2007)  Second primary cancers after prostatic irradiation: ensuring an appropriate analysis.  <i>Cancer<\/i>, 109, 164; author reply 165.","DOI":"10.1002\/cncr.22377"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Khanna, L., Prasad, S.R., Yedururi, S., Parameswaran, A.M., Marcal, L.P., Sandrasegaran, K., Tirumani, S.H., Menias, C.O. &amp; Katabathina, V.S.(2021)  Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional Imaging Findings.  <i>Radiographics<\/i>, 41, 876-894.","DOI":"10.1148\/rg.2021200171"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Laconi, E., Marongiu, F. &amp; DeGregori, J.(2020)  Cancer as a disease of old age: changing mutational and microenvironmental landscapes.  <i>Br. J. Cancer<\/i>, 122, 943-952.","DOI":"10.1038\/s41416-019-0721-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Liao, L.J., Chou, H.W., Wang, C.T., Chung, C.S. &amp; Lai, M.S.(2013)  The impact of second primary malignancies on head and neck cancer survivors: a nationwide cohort study.  <i>PLoS One<\/i>, 8, e62116.","DOI":"10.1371\/journal.pone.0062116"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Lopez-Beltran, A., Cheng, L., Montorsi, F., Scarpelli, M., Raspollini, M.R. &amp; Montironi, R.(2017)  Concomitant bladder cancer and prostate cancer: challenges and controversies.  <i>Nat. Rev. Urol<\/i>., 14, 620-629.","DOI":"10.1038\/nrurol.2017.124"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Morton, L.M., Onel, K., Curtis, R.E., Hungate, E.A. &amp; Armstrong, G.T.(2014)  The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults.  <i>Am. Soc. Clin. Oncol. Educ. Book<\/i>., 34, e57-67.","DOI":"10.14694\/EdBook_AM.2014.34.e57"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Murray, L., Henry, A., Hoskin, P., Siebert, F.A.,  Venselaar, J. &amp; PROBATE group of GEC ESTRO(2014)  Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique.  <i>Radiother. Oncol<\/i>., 110, 213-228.","DOI":"10.1016\/j.radonc.2013.12.012"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Sato, T., Sano, T., Kawamura, S., Ikeda, Y., Orikasa, K., Tanaka, T., Kyan, A., Ota, S., Tokuyama, S., Saito, H., Mitsuzuka, K., Yamashita, S., Arai, Y., Kobayashi, T. &amp; Ito, A.(2023)  Improving compliance with guidelines may lead to favorable clinical outcomes for patients with non-muscle-invasive bladder cancer: A retrospective multicenter study.  <i>Int. J. Urol<\/i>., 30, 1155-1163.","DOI":"10.1111\/iju.15294"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Sylvester, R.J., van der Meijden, A.P., Oosterlinck, W., Witjes, J.A., Bouffioux, C., Denis, L., Newling, D.W. &amp; Kurth, K.(2006)  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk Tables: a combined analysis of 2596 patients from seven EORTC trials.  <i>Eur. Urol<\/i>., 49, 466-475; discussion 475-477.","DOI":"10.1016\/j.eururo.2005.12.031"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Travis, L.B., Rabkin, C.S., Brown, L.M., Allan, J.M., Alter, B.P., Ambrosone, C.B., Begg, C.B., Caporaso, N., Chanock, S., DeMichele, A., Figg, W.D., Gospodarowicz, M.K., Hall, E.J., Hisada, M., Inskip, P.,  et al.(2006)  Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.  <i>J. Natl. Cancer Inst<\/i>., 98, 15-25.","DOI":"10.1093\/jnci\/djj001"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Wallis, C.J., Mahar, A.L., Choo, R., Herschorn, S., Kodama, R.T., Shah, P.S., Danjoux, C., Narod, S.A. &amp; Nam, R.K.(2016)  Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis.  <i>BMJ<\/i>, 352, i851.","DOI":"10.1136\/bmj.i851"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Yee, D.S., Shariat, S.F., Lowrance, W.T., Sterbis, J.R., Vora, K.C., Bochner, B.H., Donat, S.M., Herr, H.W., Dalbagni, G. &amp; Sandhu, J.S.(2010)  Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.  <i>J. Urol<\/i>., 183, 1751-1756.","DOI":"10.1016\/j.juro.2010.01.014"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/266\/1\/266_2024.J109\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T04:40:20Z","timestamp":1748061620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/266\/1\/266_2024.J109\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2024.j109","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"type":"print","value":"0040-8727"},{"type":"electronic","value":"1349-3329"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2024.J109"}}